Your browser doesn't support javascript.
loading
Methods of Esthetic Assessment after Adjuvant Whole-Breast Radiotherapy in Breast Cancer Patients: Evaluation of the BCCT.core Software and Patients' and Physicians' Assessment from the Randomized IMRT-MC2 Trial.
Forster, Tobias; Köhler, Clara; Dorn, Melissa; Häfner, Matthias Felix; Arians, Nathalie; König, Laila; Harrabi, Semi Ben; Schlampp, Ingmar; Meixner, Eva; Heinrich, Vanessa; Weidner, Nicola; Golatta, Michael; Hennigs, André; Heil, Jörg; Hof, Holger; Krug, David; Debus, Jürgen; Hörner-Rieber, Juliane.
Afiliação
  • Forster T; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Köhler C; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.
  • Dorn M; National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Häfner MF; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Arians N; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • König L; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Harrabi SB; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.
  • Schlampp I; National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Meixner E; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Heinrich V; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.
  • Weidner N; National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Golatta M; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Hennigs A; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.
  • Heil J; National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Hof H; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Krug D; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.
  • Debus J; National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Hörner-Rieber J; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Cancers (Basel) ; 14(12)2022 Jun 18.
Article em En | MEDLINE | ID: mdl-35740675
ABSTRACT
The present analysis compares the esthetics assessment by the BCCT.core software in relation to patients' and physicians' ratings, based on the IMRT-MC2 trial. Within this trial, breast cancer patients received breast-conserving surgery (BCS) and adjuvant radiotherapy. At the baseline, 6 weeks, and 2 years after radiotherapy, photos of the breasts were assessed by the software and patients' and physicians' assessments were performed. Agreement rates of the assessments and their correlation with breast asymmetry indices were evaluated. The assessments of the software and the physicians were significantly correlated with asymmetry indices. Before and 6 weeks after radiotherapy, the patients' self-assessment was only correlated with the lower breast contour (LBC) and upward nipple retraction (UNR), while after 2 years, there was also a correlation with other indices. Only a slight agreement between the BCCT.core software and the physicians' or patients' assessment was seen, while a moderate and substantial agreement was detected between the physicians' and the patients' assessment after 6 weeks and 2 years, respectively. The BCCT.core software is a reliable tool to measure asymmetries, but may not sufficiently evaluate the esthetic outcome as perceived by patients. It may be more appropriate for a long-term follow-up, when symmetry appears to increase in importance.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha